TOJA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 166
EU - Europa 53
AS - Asia 18
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 1
Totale 252
Nazione #
US - Stati Uniti d'America 157
IT - Italia 44
BD - Bangladesh 14
CA - Canada 6
GB - Regno Unito 5
BR - Brasile 1
CR - Costa Rica 1
EE - Estonia 1
FR - Francia 1
HK - Hong Kong 1
ID - Indonesia 1
IE - Irlanda 1
JM - Giamaica 1
JP - Giappone 1
NI - Nicaragua 1
NL - Olanda 1
PH - Filippine 1
Totale 238
Città #
San Jose 27
Milan 25
Ashburn 23
Council Bluffs 21
Columbus 15
Rome 6
Santa Clara 5
Dallas 2
Los Angeles 2
New York 2
Phoenix 2
Queens 2
St Louis 2
Toronto 2
Winnipeg 2
Abbeville 1
Apple Valley 1
Armação dos Búzios 1
Atlanta 1
Austin 1
Avon 1
Bologna 1
Calamba 1
Charlotte 1
Chula Vista 1
Elk Grove Village 1
Ferndale 1
Fontana 1
Harlingen 1
Hawthorne 1
Hong Kong 1
Houston 1
Kingston 1
La Vernia 1
Laveen 1
Littleton 1
Lumberton 1
Lyndhurst 1
Makassar 1
Managua 1
Mount Vernon 1
Naples 1
North Bergen 1
Parkville 1
Pescara 1
San Bernardino 1
San José 1
Scranton 1
Tillsonburg 1
Tokyo 1
Trieste 1
Turin 1
Valdosta 1
Waldorf 1
Woodbridge 1
Totale 178
Nome #
Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function 31
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP 23
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 23
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study 19
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 18
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 18
Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers 17
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 16
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum 16
Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease 15
CSF and plasma Aβ42/40 across Alzheimer s disease continuum: Comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 15
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 15
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 14
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers 12
Totale 252
Categoria #
all - tutte 1.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026104 0 0 0 0 0 0 0 0 0 0 0 104
2026/2027148 17 20 32 79 0 0 0 0 0 0 0 0
Totale 252